Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

8-K - Current report

Form Type: 8-K

Filing Date: 2013-05-08

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-04-30

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2013-04-30

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-04-24

View Filing

PRE 14A - Other preliminary proxy statements

Form Type: PRE 14A

Filing Date: 2013-04-18

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-04-09

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-03-26

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-03-26

View Filing

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q/A

Filing Date: 2013-03-25

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2013-03-25

View Filing